Highmark Inc. Publishes Commercial Coverage Policy for Nerivio ®, a Drug-Free, Dual Use Treatment for Adolescents and Adults Living with Migraine Highmark's coverage decision for the Nerivio REN ...
Jersey City-based Organon is expanding its distribution and promotion agreement with Eli Lilly and Co. for migraine medicine Emgality. Emgality, a monoclonal antibody that selectively binds to ...
Pharmaceutical Technology on MSN
AbbVie receives EC approval for Aquipta to treat migraine
The decision is supported by results from the Phase III ECLIPSE study, which assessed Aquipta versus placebo for migraine.
Highmark Inc. Publishes Commercial Coverage Policy for Nerivio ®, a Drug-Free, Dual Use Treatment for Adolescents and Adults Living with Migraine Professor Christopher Gottschalk, MD, FAHS, Neurology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results